Drug Shortage Report for ATIVAN
| Report ID | 210735 |
| Drug Identification Number | 02041448 |
| Brand name | ATIVAN |
| Common or Proper name | Ativan 2mg |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | LORAZEPAM |
| Strength(s) | 2MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 1000's |
| ATC code | N05BA |
| ATC description | ANXIOLYTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-04-25 |
| Actual start date | |
| Estimated end date | 2024-08-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-26 |
| Company comments | Sublingual presentation 2mg remain fully available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-04-26 | English | Compare |
| v4 | 2024-04-11 | French | Compare |
| v3 | 2024-04-11 | English | Compare |
| v2 | 2023-11-17 | French | Compare |
| v1 | 2023-11-17 | English | Compare |
Showing 1 to 5 of 5